ClassID:

95219

C07D335/20 - CPC Classification

Classification description:

Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems; Dibenzothiopyrans; Hydrogenated dibenzothiopyrans; Thioxanthenes with hydrocarbon radicals, substituted by amino radicals, directly attached in position 9

Recent Application in this class:
#1
20260062386
2026-03-05

POLYMERIZABLE FUSED TRICYCLIC COMPOUNDS AS ABSORBERS OF UV AND VISIBLE LIGHT

#2
20220313656
2022-10-06

NEW CLASS OF ANTIBIOTICS HAVING LOW MIC-VALUES TOWARDS DIFFERENT STRAINS OF BACTERIA

#3
20200407324
2020-12-31

POLYMERIZABLE FUSED TRICYCLIC COMPOUNDS AS ABSORBERS OF UV AND VISIBLE LIGHT

#4
20190031639
2019-01-31

Zuclopenthixol hydrochloride derivatives and Ebselen derivatives as ErbB2 inhibitors

#5
20170317283
2017-11-02

Materials for organic electroluminescent devices

#6
20170088534
2017-03-30

3,6-disubstituted xanthylium salts

#7
20140066451
2014-03-06

THIOXANTHENE DERIVATIVES FOR THE TREATMENT OF INFECTIOUS DISEASES

#8
20130231484
2013-09-05

Compounds having photochemically removable protecting groups based on an electrocyclic reaction between a chromophore attached via an anilide group to a benzothiophene ring

#9
20120122880
2012-05-17

Thioxanthene derivatives for the treatment of infectious diseases

#10
20110300074
2011-12-08

3,6-disubstituted xanthylium salts and use thereof in treatment of tauopathies

#11
20090159874
2009-06-25

Organic electroluminescent devices

#12
20070088016
2007-04-19

Tricyclic steroid hormone nuclear receptor modulators

#13
20070054410
2007-03-08

Dithio compounds

#14
20060204871
2006-09-14

Organic photoconductive material electrophotographic photoreceptor and image forming apparatus using the same

#15
20060142594
2006-06-29

Compounds active at a novel site on receptor-operated calcium channels useful for treatment of neurological disorders and diseases

#16
20060079527
2006-04-13

Piperazine derivatives having SST1 antagonistic activity

#17
20060025471
2006-02-02

Xanthenyl cubane analogs with activity at the metabotropic glutamate receptors